Home / Medroxyprogesterone / Czechia
CZ ATC L02AB02 · updated 2 Nov 2026
Medroxyprogesterone shortage in Czechia
Is there a Medroxyprogesterone shortage in Czechia?
Yes. As of 2 Nov 2026, 2 Medroxyprogesterone products are reported short in Czechia, the first since 1 Sep 2026. The company estimate for the return is 7 Dec 2026 (latest 11 Jan 2027). Main reason: manufacturing problem.
Also short in Germany, France. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | PROVERA 500MG 500MG TBL NOB 20 II | Pfizer, spol. s r.o., Praha | 1 Sep 2026 | 7 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | PROVERA 100MG 100MG TBL NOB 100 II anticipated | Pfizer, spol. s r.o., Praha | 30 Nov 2026 | 11 Jan 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.